tiprankstipranks
CG Oncology, Inc. (CGON)
NASDAQ:CGON
US Market

CG Oncology, Inc. (CGON) Income Statement

Compare
130 Followers

CG Oncology, Inc. Income Statement

Last quarter (Q3 2024), CG Oncology, Inc.'s total revenue was $43.00K, an increase of 377.78% from the same quarter last year. In Q3, CG Oncology, Inc.'s net income was $-20.41M. See CG Oncology, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21
Total Revenue
$ 204.00K$ 191.00K$ 10.36M
Gross Profit
$ 204.00K$ 176.00K$ 10.35M
Operating Expenses
$ 55.65M$ 35.42M$ 22.95M
Depreciation and Amortization
$ 17.00K$ 15.00K$ 10.00K
EBITDA
$ -55.43M$ -35.23M$ -12.38M
Operating Income
$ -55.45M$ -35.25M$ -12.61M
Other Income/Expenses
$ 6.84M$ -197.00K$ -233.00K
Pretax Income
$ -48.61M$ -35.44M$ -12.84M
Net Income
$ -48.61M$ -35.44M$ -12.84M
Per Share Metrics
$ ―$ ―$ ―
Basic EPS
$ -15.65$ -0.53$ -0.19
Diluted EPS
$ -15.65$ -0.53$ -0.19
Weighted Average Shares Outstanding
4.33M 66.64M 66.64M
Weighted Average Shares Outstanding (Diluted)
4.33M 66.64M 66.64M
Currency in USD

CG Oncology, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis